2.1(top 20%)
impact factor
3.9K(top 5%)
papers
96.6K(top 5%)
citations
114(top 5%)
h-index
2.2(top 20%)
impact factor
5.1K
all documents
102.3K
doc citations
182(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety20071,338
2Validation of the national health insurance research database with ischemic stroke cases in TaiwanPharmacoepidemiology and Drug Safety20111,139
3Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety20011,018
4Methods for evaluation of medication adherence and persistence using automated databasesPharmacoepidemiology and Drug Safety2006867
5A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiology and Drug Safety2002822
6Increasing deaths from opioid analgesics in the United StatesPharmacoepidemiology and Drug Safety2006620
7Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeuticsPharmacoepidemiology and Drug Safety2006585
8Quantitative signal detection using spontaneous ADR reportingPharmacoepidemiology and Drug Safety2009551
9Validation studies of the health improvement network (THIN) database for pharmacoepidemiology researchPharmacoepidemiology and Drug Safety2007535
10The reporting odds ratio and its advantages over the proportional reporting ratioPharmacoepidemiology and Drug Safety2004486
11Trends in long‐term opioid therapy for chronic non‐cancer painPharmacoepidemiology and Drug Safety2009484
12Immortal time bias in observational studies of drug effectsPharmacoepidemiology and Drug Safety2007462
13The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiologyPharmacoepidemiology and Drug Safety2017382
14One‐to‐many propensity score matching in cohort studiesPharmacoepidemiology and Drug Safety2012373
15Increasing off‐label use of antipsychotic medications in the United States, 1995–2008Pharmacoepidemiology and Drug Safety2011365
16A synthesis of oral morphine equivalents (OME) for opioid utilisation studiesPharmacoepidemiology and Drug Safety2016322
17Principles for modeling propensity scores in medical research: a systematic literature reviewPharmacoepidemiology and Drug Safety2004296
18Hy's law: predicting serious hepatotoxicityPharmacoepidemiology and Drug Safety2006294
19An automated database case definition for serious bleeding related to oral anticoagulant usePharmacoepidemiology and Drug Safety2011291
20The relationship between time since registration and measured incidence rates in the General Practice Research DatabasePharmacoepidemiology and Drug Safety2005289
21Instrumental variable methods in comparative safety and effectiveness researchPharmacoepidemiology and Drug Safety2010288
22Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three‐year period in an elderly populationPharmacoepidemiology and Drug Safety2011284
23Guidelines for good database selection and use in pharmacoepidemiology researchPharmacoepidemiology and Drug Safety2012283
24A systematic review of validated methods for identifying atrial fibrillation using administrative dataPharmacoepidemiology and Drug Safety2012280
25Adverse drug events in the outpatient setting: an 11‐year national analysisPharmacoepidemiology and Drug Safety2010260
26The importance of defining periods of complete mortality reporting for research using automated data from primary carePharmacoepidemiology and Drug Safety2009259
27Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta‐analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level dataPharmacoepidemiology and Drug Safety2011259
28Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision makingPharmacoepidemiology and Drug Safety2017251
29Recent changes in drug poisoning mortality in the United States by urban–rural status and by drug typePharmacoepidemiology and Drug Safety2008250
30On principles for modeling propensity scores in medical researchPharmacoepidemiology and Drug Safety2004248
31Further validation of information recorded on a general practitioner based computerized data resource in the united kingdomPharmacoepidemiology and Drug Safety1992241
32Estimates of acetaminophen (paracetomal)-associated overdoses in the United StatesPharmacoepidemiology and Drug Safety2006239
33Trends in the use of aspirin and nonsteroidal anti‐inflammatory drugs in the general U.S. populationPharmacoepidemiology and Drug Safety2014235
34Hospitalisations and emergency department visits due to drug–drug interactions: a literature reviewPharmacoepidemiology and Drug Safety2007233
35A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative dataPharmacoepidemiology and Drug Safety2012224
36A basic study design for expedited safety signal evaluation based on electronic healthcare dataPharmacoepidemiology and Drug Safety2010223
37Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR ProjectPharmacoepidemiology and Drug Safety2011222
38A systematic review of validated methods for identifying heart failure using administrative dataPharmacoepidemiology and Drug Safety2012209
39Use of herbal drugs in pregnancy: a survey among 400 Norwegian womenPharmacoepidemiology and Drug Safety2004206
40Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformationsPharmacoepidemiology and Drug Safety2007206
41Design considerations, architecture, and use of the Mini‐Sentinel distributed data systemPharmacoepidemiology and Drug Safety2012204
42Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta‐analysisPharmacoepidemiology and Drug Safety2014204
43Screening statins for possible carcinogenic risk: up to 9 years of follow‐up of 361 859 recipientsPharmacoepidemiology and Drug Safety2008203
44Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studiesPharmacoepidemiology and Drug Safety2005202
45The Chang Gung Research Database—A multi‐institutional electronic medical records database for real‐world epidemiological studies in TaiwanPharmacoepidemiology and Drug Safety2019200
46QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting systemPharmacoepidemiology and Drug Safety2005198
47Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United StatesPharmacoepidemiology and Drug Safety2007198
48Guidelines for good pharmacoepidemiology practices (GPP)Pharmacoepidemiology and Drug Safety2008195
49Evaluating uses of data mining techniques in propensity score estimation: a simulation studyPharmacoepidemiology and Drug Safety2008195
50Prescription drug use during pregnancy in developed countries: a systematic reviewPharmacoepidemiology and Drug Safety2011189